Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
By
Wei Li
Hui Xu
July 14, 2026
Clinical Scorecard: Dermatologic Reactions in Patients Undergoing EGFR-Pathway Targeted Therapies: Clinical Presentation, Evidence Limitations, Follicular Inflammation, and Treatment Approaches
At a Glance
Category Detail
Condition Papulopustular eruption associated with EGFR inhibitors Key Mechanisms KLF4/IL-36γ signaling and Cutibacterium acnes-amplified neutrophilic inflammation Target Population Patients undergoing EGFR-pathway targeted therapies Care Setting Oncology and dermatology clinics
Key Highlights
Papulopustular eruption is distinct from acne vulgaris, characterized by absence of comedones. Eruptions commonly occur in seborrheic areas such as the face, scalp, chest, and upper back. Management strategies have evolved towards early prevention and phenotype-oriented assessment. Evidence for conventional care is stronger compared to refractory or scalp-predominant presentations. MEK inhibitors can cause overlapping dermatologic reactions similar to those of EGFR inhibitors. Guideline-Based Recommendations
Diagnosis
Distinguish papulopustular eruption from acne vulgaris based on clinical presentation. Management
Implement pre-emptive management strategies for EGFR inhibitor-associated eruptions. Monitoring & Follow-up
Monitor for signs of bacterial superinfection in atypical or refractory cases. Risks
Dermatologic toxicities may impair quality of life and treatment continuity. Patient & Prescribing Data
Patients receiving EGFR-targeted therapies, including anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors.
Management may require adjustments based on the severity and type of dermatologic reaction.
Clinical Best Practices
Assess for other EGFR inhibitor-associated mucocutaneous changes. Consider culture and biopsy in atypical or treatment-resistant cases. Related Resources & Content
